查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲肺癌筛检市场预测至 2030 年 - 区域分析 - 按癌症类型、技术、年龄组（50 岁及以上和 50 岁以下）和最终用户（医院、诊断中心等）
市场调查报告书
商品编码
1402532

南美洲和中美洲肺癌筛检市场预测至 2030 年 - 区域分析 - 按癌症类型、技术、年龄组（50 岁及以上和 50 岁以下）和最终用户（医院、诊断中心等）

South & Central America Lung Cancer Screening Market Forecast to 2030 - Regional Analysis- by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
出版日期: | 出版商: The Insight Partners | 英文 100 Pages | 订单完成后即时交付

价格

南美洲和中美洲肺癌筛检市场预计将从2022年的3,916万美元成长到2030年的6,895万美元。预计2022年至2030年CAGR为7.3%。

肺癌筛检测试的高成本推动了南美洲和中美洲肺癌筛检市场。

随着该地区医疗保健意识的不断增强，该地区的肺癌筛检提供者拥有充足的机会。其中包括与地区医院和诊所合作，透过这些医院和诊所可以提供方便的肺癌筛检，并利用偏远地区的远距医疗。这种方法不仅能及早发现肺癌，还能改善病患的治疗效果，填补该地区医疗保健的关键空白。透过满足预防性护理不断增长的需求，这些提供者可以在前景广阔的市场中站稳脚跟，最终为改善整个地区的公共卫生和福祉做出贡献。

南美洲和中美洲肺癌筛检市场概述

南美洲和中美洲肺癌筛检市场分为巴西、阿根廷以及南美洲和中美洲其他地区。该地区的成长归因于多种因素，例如肺癌发病率的增加和人们对肺癌筛检意识的增强。此外，政府对筛检的支持不断增加，导致市场进一步成长。

肺癌筛检市场正受到癌症盛行率上升等因素的影响。例如，根据 Globocan 2020 报告，肺癌是巴西第二大流行癌症。巴西新增肺癌病例88492例。

肺癌筛检被认为是全世界的照护标准。在巴西，其实施过程中的复杂因素与卫生系统的组织、CT 扫描和治疗方法的获取以及对该方法的文化接受程度有关，限制了这一进程。根据当地组织的说法，进行筛检存在挑战和障碍；然而，在所有情况下都有可能获得令人满意的结果。

据肺癌政策网络称，在巴西，有必要采取协调一致的肺癌筛检方法，因为全国各地的卫生援助分散，并导致了严重的健康不平等。最近，第二次巴西早期肺癌筛检试验 (BRELT2) 描述了 LDCT 筛检的优点。儘管如此，在全国范围内实施有组织的筛检计画之前，仍有许多障碍需要克服，包括公共和私人医疗保健机构之间使用筛检设备的不平等。为了应对这项挑战，作为 Propulmao 移动计画的一部分，巴雷托斯（圣保罗）市卫生办公室与当地癌症医院合作，在社区提供行动 LDCT 筛检和戒烟干预措施。

南美洲及中美洲肺癌筛检市场收入及 2030 年预测（百万美元）

南美洲和中美洲肺癌筛检市场细分

南美洲和中美洲肺癌筛检市场细分为癌症类型、技术、年龄层、最终用户和国家。

根据癌症类型，南美洲和中美洲肺癌筛检市场分为非小细胞肺癌（NSCLC）和小细胞肺癌。 2022 年，非小细胞肺癌 (NSCLC) 细分市场在南美洲和中美洲肺癌筛检市场中占据更大份额。

根据技术，南美洲和中美洲肺癌筛检市场分为胸部 X 光、低剂量电脑断层扫描 (LDCT)、液体活检等。 2022 年，胸部 X 光检查在南美洲和中美洲肺癌筛检市场中占据最大份额。

根据年龄组，南美洲和中美洲肺癌筛检市场分为50岁及以上和50岁以下。2022年，50岁及以上人口在南美洲和中美洲肺癌筛检市场中占据较大份额。

根据最终用户，南美洲和中美洲肺癌筛检市场分为医院、诊断中心等。 2022 年，医院细分市场在南美洲和中美洲肺癌筛检市场中占据最大份额。

根据国家/地区，南美洲和中美洲肺癌筛检市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，巴西在南美洲和中美洲肺癌筛检市场占据主导地位。

西门子股份公司、荷兰皇家飞利浦公司、佳能公司、美敦力公司和通用电气医疗保健技术公司是南美洲和中美洲肺癌筛检市场的一些领导公司。

目录

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 南美洲和中美洲肺癌筛检市场 - 按技术分类
    • 南美洲和中美洲肺癌筛检市场 - 按癌症类型
    • 南美洲和中美洲肺癌筛检市场 - 按年龄组
    • 南美洲和中美洲肺癌筛检市场 - 按最终用户划分
    • 南美洲和中美洲肺癌筛检市场 - 按国家/地区

第 2 章：南美洲和中美洲肺癌筛检市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲肺癌筛检市场 - 市场格局

  • 概述
  • 南美洲和中美洲 PEST 分析
  • 专家意见

第 5 章：南美洲和中美洲肺癌筛检市场 - 主要市场动态

  • 市场驱动因素
    • 肺癌发生率上升
  • 市场限制
    • 肺癌筛检测试成本高昂
  • 市场机会
    • 与地区医院和诊所的合作
  • 未来的趋势
    • 使用尖端技术
  • 影响分析

第 6 章：肺癌筛检市场 - 南美洲和中美洲分析

  • 南美洲和中美洲肺癌筛检市场收入预测与分析

第 7 章：南美洲和中美洲肺癌筛检市场 - 收入和 2028 年预测 - 按癌症类型

  • 概述
  • 2022 年和 2030 年南美洲和中美洲肺癌筛检市场收入份额（按癌症类型划分）
  • 非小细胞肺癌 (NSCLC)
  • 小细胞肺癌

第 8 章：南美洲和中美洲肺癌筛检市场分析 - 按技术

  • 概述
  • 低剂量电脑断层扫描 (LDCT)
  • 胸部X光检查
  • 液体活检
  • 其他的

第 9 章：南美洲和中美洲肺癌筛检市场分析 - 按年龄组

  • 概述
  • 及较旧的
  • 50以下

第 10 章：南美洲和中美洲肺癌筛检市场分析 - 按最终用户

  • 概述
  • 医院
  • 诊断中心
  • 其他的

第 11 章：南美洲和中美洲肺癌筛检市场 - 收入和 2028 年预测 - 国家分析

  • 南美洲和中美洲肺癌筛检市场概述

第 12 章：南美洲和中美洲肺癌筛检市场-产业格局

  • 近期成长策略
    • 概述

第 13 章：公司简介

  • Nuance Communications Inc
  • GE HealthCare
  • Medtronic
  • Canon Inc.
  • Koninklijke Philips NV
  • Siemens AG

第 14 章：附录

  • 关于 Insight Partners
  • 专业术语
Product Code: BMIRE00029065

The South & Central America lung cancer screening market is expected to grow from US$ 39.16 million in 2022 to US$ 68.95 million by 2030. It is estimated to grow at a CAGR of 7.3% from 2022 to 2030.

High cost of lung cancer screening tests fuel South & Central America lung cancer screening market.

Amid growing healthcare awareness in the region, lung cancer screening providers in the region has ample opportunities. These include collaborating with regional hospitals and clinics through which they can offer accessible lung cancer screening and leveraging telemedicine for remote areas. This approach not only detects lung cancer early but also improves patient outcomes, filling a crucial gap in the region's healthcare. By aligning with the rising demand for preventive care, these providers can establish a foothold in a promising market, ultimately contributing to enhanced public health and well-being across the region.

South & Central America Lung Cancer Screening Market Overview

The South & Central America lung cancer screening market is segmented into the Brazil, Argentina, and the Rest of South & Central America. The regional growth is attributed to various factors, such as the increasing incidence of lung cancer and growing awareness of lung cancer screening among people. Also, rising government support for screening has led to the further growth of the market.

The lung cancer screening market is being influenced by factors such as the increasing prevalence of cancer. For instance, as per Globocan 2020 report, lung cancer is Brazil's second most prevalent cancer. There were 88492 new cases of lung cancer found in Brazil.

Lung cancer screening is believed to be the standard of care worldwide. In Brazil, complications in its implementation related to the organization of the health system, access to CT scans and treatment methods, and cultural acceptance of the method restrict the process. There are challenges and barriers in carrying out the screening according to the local organization; however, it was possible to obtain satisfactory results in all scenarios.

According to Lung Cancer Policy Network, In Brazil, a coordinated approach to lung cancer screening is necessary, as health assistance is fragmented across the country and has resulted in significant health inequalities. The advantages of LDCT screening were recently described in the Second Brazilian Early Lung Cancer Screening Trial (BRELT2). Nevertheless, there are still many barriers to overcome before an organized screening program can be implemented nationwide, including inequitable access to screening equipment between public and private healthcare. To manage this challenge, as part of the Propulmao Mobile Project, the municipal health office in Barretos (Sao Paulo) collaborated with the local cancer hospital to deliver mobile LDCT screening and a smoking cessation intervention in the community.

South & Central America Lung Cancer Screening Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Lung Cancer Screening Market Segmentation

The South & Central America lung cancer screening market is segmented into cancer type, technology, age group, end user, and country.

Based on cancer type, the South & Central America lung cancer screening market is segmented into non-small cell lung cancer (NSCLC), and small cell lung cancer. The non-small cell lung cancer (NSCLC) segment held a larger share of the South & Central America lung cancer screening market in 2022.

Based on technology, the South & Central America lung cancer screening market is segmented into chest X-ray, low dose computed tomography (LDCT), liquid biopsy, and others. Chest X-ray segment held the largest share of the South & Central America lung cancer screening market in 2022.

Based on age group, the South & Central America lung cancer screening market is segmented into 50 and older, and below 50. 50 and older segment held the larger share of the South & Central America lung cancer screening market in 2022.

Based on end user, the South & Central America lung cancer screening market is segmented into hospital, diagnostic centre, and others. Hospital segment held the largest share of the South & Central America lung cancer screening market in 2022.

Based on country, the South & Central America lung cancer screening market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America lung cancer screening market in 2022.

Siemens AG, Koninklijke Philips NV, Canon Inc, Medtronic, and GE HealthCare technologies Inc are some of the leading companies operating in the South & Central America lung cancer screening market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Lung Cancer Screening Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America Lung Cancer Screening Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

Table of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Lung Cancer Screening Market - by Technology
    • 1.3.2 South & Central America Lung Cancer Screening Market - by Cancer Type
    • 1.3.3 South & Central America Lung Cancer Screening Market - by Age Group
    • 1.3.4 South & Central America Lung Cancer Screening Market - by End User
    • 1.3.5 South & Central America Lung Cancer Screening Market - by Country

2. South & Central America Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Lung Cancer Screening Market - Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis
  • 4.3 Expert's Opinion

5. South & Central America Lung Cancer Screening Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Lung Cancer Incidences
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Lung Cancer Screening Tests
  • 5.3 Market Opportunities
    • 5.3.1 Collaboration with Regional Hospitals and Clinics
  • 5.4 Future Trends
    • 5.4.1 Use of Cutting-Edge Technologies
  • 5.5 Impact Analysis

6. Lung Cancer Screening Market - South & Central America Analysis

  • 6.1 South & Central America Lung Cancer Screening Market Revenue Forecast and Analysis

7. South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

  • 7.1 Overview
  • 7.2 South & Central America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • 7.3 Non-Small Cell Lung Cancer (NSCLC)
    • 7.3.1 Overview
    • 7.3.2 Non-Small Cell Lung Cancer (NSCLC): South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
  • 7.4 Small Cell Lung Cancer
    • 7.4.1 Overview
    • 7.4.2 Small Cell Lung Cancer: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Lung Cancer Screening Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Low-Dose Computed Tomography (LDCT)
    • 8.2.1 Overview
    • 8.2.2 Low-Dose Computed Tomography (LDCT): South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Chest X-ray
    • 8.3.1 Overview
    • 8.3.2 Chest X-ray: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Liquid Biopsy
    • 8.4.1 Overview
    • 8.4.2 Liquid Biopsy: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Lung Cancer Screening Market Analysis - by Age Group

  • 9.1 Overview
  • 9.2 & Older
    • 9.2.1 Overview
    • 9.2.2 & Older: South & Central America Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Below 50
    • 9.3.1 Overview
    • 9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Lung Cancer Screening Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospitals
    • 10.2.1 Overview
    • 10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2028 - Country Analysis

  • 11.1 South & Central America Lung Cancer Screening Market Overview
      • 11.1.1.1 Brazil: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 Brazil: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.3 Brazil: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.1.4 Brazil: South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.5 Brazil: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.1.6 Brazil: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.2 Argentina: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Argentina: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.3 Argentina: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.2.4 Argentina: South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.5 Argentina: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.2.6 Argentina: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 Rest of South & Central America: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Rest of South & Central America: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.3 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.3.4 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.5 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.3.6 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12. South & Central America Lung Cancer Screening Market-Industry Landscape

  • 12.1 Recent Growth Strategies
    • 12.1.1 Overview

13. Company Profiles

  • 13.1 Nuance Communications Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 GE HealthCare
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Medtronic
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Canon Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Koninklijke Philips NV
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Siemens AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

List of Tables

  • Table 1. Brazil South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 2. Brazil South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Brazil South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Argentina South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 6. Argentina South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Argentina South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Argentina South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Rest of South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 10. Rest of South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Rest of South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Rest of South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Recent Growth Strategies in the South & Central America Lung Cancer Screening Market
  • Table 14. Glossary of Terms

List Of Figures

List of Figures

  • Figure 1. South & Central America Lung Cancer Screening Market Segmentation
  • Figure 2. South & Central America Lung Cancer Screening Market, by Country
  • Figure 3. South & Central America Lung Cancer Screening Market Overview
  • Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in South & Central America Lung Cancer Screening Market
  • Figure 5. South & Central America Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. South & Central America: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. South & Central America Lung Cancer Screening Market Impact Analysis of Driver and Restraints
  • Figure 9. South & Central America Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
  • Figure 10. South & Central America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • Figure 11. Non-Small Cell Lung Cancer (NSCLC): South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Small Cell Lung Cancer: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. South & Central America Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
  • Figure 14. Low-Dose Computed Tomography (LDCT): South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Chest X-ray: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Liquid Biopsy: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. South & Central America Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
  • Figure 19. & Older: South & Central America Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. South & Central America Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
  • Figure 22. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South & Central America Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Mn)
  • Figure 26. South & Central America Lung Cancer Screening Market Revenue Share, by Key Country (2022 and 2030)
  • Figure 27. Brazil: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Argentina: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Rest of South & Central America: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)